Article
Novel phosphoramide ligand shows promise as a cytotoxic agent against breast cancer: Molecular docking, ADMET studies and quantum studies
2025-07-01
Abstract excerpt
Breast cancer is a global health concern, often treated with surgery, radiation therapy, and chemotherapy. Phosphoramides, a class of organophosphorus compounds, have shown potential in various applications, including antitumor and anticancer activities. This study focuses on novel phosphoramide ligands ( L1,L2,L3 ) and their cytotoxic effects on human breast cancer cells (MDA-MB-231). Ligand ( L1 ) was synthesize...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1fff0d0e-18ac-5c9f-8d57-c0d79934fbea
- DOI
- 10.1016/j.rechem.2025.102520
